Executive Order October 07, 2025 Doc #2025-19495 Executive Order 14355

Unlocking Cures for Pediatric Cancer With Artificial Intelligence

Healthcare Technology Government Reform Infrastructure

💡

In Simple Terms

The President wants to use AI to find better ways to treat and cure cancer in kids. This plan will boost research and use new tech to help doctors and scientists.

Summary

On September 30, 2025, President Donald Trump issued Executive Order 14355, titled "Unlocking Cures for Pediatric Cancer With Artificial Intelligence." This order directs the Make America Healthy Again (MAHA) Commission to collaborate with various federal entities to harness AI technology in combating pediatric cancer, which remains the leading cause of disease-related death among children in the U.S. The initiative aims to improve data infrastructure, enhance predictive modeling, and optimize clinical trials through AI, building on the existing Childhood Cancer Data Initiative. The order also emphasizes increasing federal investment and encouraging private sector engagement in AI-driven pediatric cancer research, while ensuring patient data privacy and interoperability.

Official Record

Federal Register Published

Signed by the President

September 30, 2025

Published in Federal Register

View on Federal Register View Printed Version (PDF)

October 07, 2025

Document #2025-19495

Analysis & Impact

💡 How This May Affect You

Working families and individuals: May benefit from improved pediatric cancer treatments, reducing healthcare burdens and emotional stress.
Small business owners: Could face increased demand for AI solutions, creating opportunities for tech-based businesses.
Students and recent graduates: New research and tech jobs in healthcare and AI could provide career opportunities.
Retirees and seniors: Indirect benefit through enhanced healthcare systems and potential advancements in cancer treatments.
Different regions (urban, suburban, rural): Urban areas might see faster implementation, while rural regions could benefit from improved data sharing.

🏢 Key Stakeholders

Pediatric cancer patients benefit from accelerated AI-driven diagnostics and treatments.
Healthcare AI developers gain opportunities to innovate in pediatric oncology.
National Cancer Institute leads AI integration in pediatric cancer research.
Pharmaceutical industry faces challenges adapting to AI-focused clinical trial designs.
Childhood Cancer Data Initiative expands its role in data infrastructure enhancement.

📈 What to Expect

Short-term:
- Increased funding for AI-driven pediatric cancer research projects.
- Establishment of AI-integrated data platforms at cancer centers.
Long-term:
- Enhanced pediatric cancer diagnostic and treatment capabilities.
- Improved clinical trial accessibility and outcomes via AI tools.

📚 Historical Context

Mirrors President Nixon's 1971 National Cancer Act, focusing on cancer research and innovation.
Builds on President Obama's 2016 Cancer Moonshot, emphasizing data and technology in cancer treatment.
Modifies President Trump's 2019 Childhood Cancer Data Initiative by integrating AI for data analysis.
Notable for prioritizing AI in healthcare, a novel approach in presidential cancer research efforts.
Highlights a shift towards public-private partnerships in medical innovation, unlike previous federal-centric models.